-
Magnetoencephalography (MEG): Considerations vs. EEG for Clinical and Research Applications – A Moving Target?
Timothy P.L. RobertsDone
-
Low-level multisensory processes: from the impact of early life experience to the prediction of higher-order cognition
Micah M. MurrayDone
-
A near real-time computational engine for estimating TMS-induced electric fields with applications to mapping and beyond
Evgenii Kim, PhDDone
-
Clinical Applications of EEG in Children
Sudha Kilaru Kessler, MD, MSCEDone
-
How to use biomarkers in closed-loop neuromodulation
Marom Bikson, PhDDone
-
Insights Offered by Advanced Signal Processing Analysis of High-Density EEG of Term Low-risk Newborns
Dr. RB GovindanDone
-
High-Intensity Targeted HD-tDCS for Motor Skill Learning
Gavin HsuDone
-
Precision in TMS motor mapping and neuromodulation targeting: Clinical relevance and updates
Dylan Edwards, PhDDone
-
Neural and Intergenerational Markers of Psychopathology Risk in Youth
Lauren K. White, PhDDone
-
Personalized therapeutic brain-stimulation with real-time EEG-synchronized TMS
Christoph Zrenner, MDDone
Romain received his PhD in Medicine and Health Sciences from Gent University, Belgium. During his doctoral studies, he focused on the use of neuromodulation techniques to treat major depressive disorders. More specifically, he developed and tested a new stimulation protocol (accelerated iTBS) in treatment-resistant depressed patients.
Romain also investigated the role of the reward system and anhedonia in the response to stimulation in the healthy and depressed state, at the behavioral and neuroimaging level (fMRI). Thanks to many collaborations and to his background in Molecular and Cellular Biology, Romain acquired a translational knowledge of rTMS neuromechanisms of action in the human brain and in animal models. More recently, at the university of Pennsylvania, Romain used advanced interleaved TMS/fMRI setups to examine innovative TMS targeting methods taking into account individual variability. Ultimately, his goal was to better understand the factors involved in rTMS clinical response to optimize treatment protocols in depressive and anxiety disorders.